1.
Dutch Physician’s Perspectives on Diagnosis and Treatment of Waldenström’s Macroglobulinemia Before and After the Implementation of a National Guideline
Primary therapy and survival among patients with nodular lymphocyte‐predominant Hodgkin lymphoma: a population‐based analysis in the Netherlands, 1993–2016
Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
Conditional relative survival in Waldenström’s macroglobulinaemia: a population‐based study in The Netherlands
Conditional relative survival in Waldenström's macroglobulinaemia: a population-based study in The Netherlands
Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in the Netherlands, 1989–2018
Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population-based study in the Netherlands, 1989-2018
Conditional relative survival among patients with follicular lymphoma: a population-based study in the Netherlands
Risk of second primary malignancies in patients with follicular lymphoma: a population-based study in the Netherlands, 1989-2018
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands